Press release
Joint Pain Injections Market: USD 6.4 Billion in 2024 to USD 12.1 Billion by 2034 at 6.7% CAGR
Joint Pain Injections Market
Expanding geriatric population, regenerative treatment innovations, and rising sports injuries are accelerating demand for joint pain injections worldwide.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72379
Introduction
The Joint Pain Injections Market is gaining rapid traction as the global population ages and demand rises for minimally invasive, long-lasting pain management solutions.
Valued at USD 6.4 billion in 2024, the market is projected to reach USD 12.1 billion by 2034, growing at a CAGR of 6.7%.
Driven by the increasing incidence of osteoarthritis, rheumatoid arthritis, and sports-related joint damage, the market is transitioning from conventional corticosteroid treatments to biologic and regenerative injection therapies that promote healing and mobility restoration.
Key Players in the Market
The market features a diverse mix of established pharmaceutical leaders and regenerative-medicine innovators.
Major players include:
• Sanofi S.A.
• Pfizer Inc.
• Johnson & Johnson (DePuy Synthes)
• Bioventus LLC
• Seikagaku Corporation
• Zimmer Biomet Holdings Inc.
• Ferring Pharmaceuticals
• Anika Therapeutics Inc.
• Orthogen AG
• Hyalex Orthopaedics Inc.
These companies are investing in hyaluronic acid formulations, platelet-rich plasma (PRP), and stem-cell-based injectables, expanding their portfolios to include next-generation regenerative joint care products.
Key Events in the Last Five Years
• 2020-2021: Surge in osteoarthritis cases linked to sedentary lifestyles during the pandemic increased corticosteroid and HA injection use.
• 2022: Bioventus launched its next-generation Durolane® HA gel for knee osteoarthritis.
• 2023: Anika Therapeutics received regulatory approval for its Cingal® combination injection (HA + corticosteroid) in several markets.
• 2024: Growth in regenerative joint therapy research led to expanding clinical use of PRP and autologous stem-cell injections for chronic pain management.
Market Growth Rate
According to Exactitude Consultancy, the global joint pain injections market is expected to grow at a CAGR of 6.7% (2025-2034), fueled by:
• Rising prevalence of musculoskeletal and degenerative joint disorders.
• Growing adoption of biologic and autologous injectables.
• Increased healthcare expenditure and insurance coverage for outpatient pain therapies.
• Strong R&D investments in viscosupplementation and cell-based therapies.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72379/joint-pain-injections-market
Market Segments and Growth Analysis
The joint pain injections market is segmented by product type, joint type, end user, and region.
By Product Type:
• Corticosteroid Injections
• Hyaluronic Acid (Viscosupplementation)
• Platelet-Rich Plasma (PRP) Therapy
• Stem-Cell Therapy
• Combination Therapies
By Joint Type:
• Knee Joint
• Shoulder Joint
• Hip Joint
• Others (Elbow, Ankle, Wrist)
By End User:
• Hospitals & Orthopedic Clinics
• Ambulatory Surgical Centers (ASCs)
• Sports & Rehabilitation Centers
By Region:
• North America: Largest share, supported by advanced pain clinics and FDA-approved biologic products.
• Europe: Growing adoption of PRP and combination therapy in outpatient orthopedics.
• Asia Pacific: Fastest-growing market due to rising sports injuries and aging demographics in Japan, India, and China.
• Latin America & MEA: Improving healthcare access and growing awareness of regenerative orthopedics.
Key Market Drivers
1. Regenerative and Biologic Advances:
Increasing preference for PRP and stem-cell-based injectables that promote tissue regeneration and reduce dependency on surgery.
2. Aging Population and Osteoarthritis Prevalence:
Over 500 million people worldwide are affected by osteoarthritis, creating consistent demand for pain-relief injections.
3. Minimally Invasive Pain Management:
Outpatient joint injection procedures are gaining popularity as safer, cost-effective alternatives to surgical interventions.
4. Expansion of Sports Medicine:
Rising participation in high-impact sports and the growing trend of preventive orthopedics are fueling market demand.
Recent Developments
• 2023: Zimmer Biomet partnered with CartiHeal to commercialize biomaterial-based injectable scaffolds for cartilage repair.
• 2024: Pfizer invested in R&D to develop a biologic intra-articular formulation for chronic inflammatory arthritis.
• 2024: Orthogen AG launched Orthokine® Next-Gen, a protein-based injection for joint and tendon regeneration.
• 2024: Sanofi began trials for a long-acting corticosteroid microsphere injection aimed at extending efficacy duration.
Expert Insight
"The future of joint pain management lies in regenerative orthopedics. Biologic injectables are not only reducing pain but also actively repairing cartilage and delaying surgical interventions,"
- Dr. Michael Tan, Orthopedic Surgeon, Johns Hopkins University.
Conclusion
The Joint Pain Injections Market is undergoing a paradigm shift-from pain suppression to joint restoration.
With advancements in viscosupplementation, PRP therapy, and cell-based injections, patients now have access to minimally invasive, regenerative solutions that improve mobility and quality of life.
As R&D investment and clinical acceptance continue to grow, the global market is poised for robust expansion through 2034.
This report is also available in the following languages : Japanese (関節痛注射市場), Korean (관절 통증 주사 시장), Chinese (关节疼痛注射市场), French (Marché des injections contre les douleurs articulaires), German (Markt für Injektionen gegen Gelenkschmerzen), and Italian (Mercato delle iniezioni per il dolore articolare), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72379
Our More Reports:
Isovaleric Acidemia Market
https://exactitudeconsultancy.com/reports/72053/isovaleric-acidemia-market
Metachromatic Leukodystrophy Market
https://exactitudeconsultancy.com/reports/72057/metachromatic-leukodystrophy-market
Prediabetes Market
https://exactitudeconsultancy.com/reports/72063/prediabetes-market
Subarachnoid Hemorrhage Market
https://exactitudeconsultancy.com/reports/72076/subarachnoid-hemorrhage-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Joint Pain Injections Market: USD 6.4 Billion in 2024 to USD 12.1 Billion by 2034 at 6.7% CAGR here
News-ID: 4259202 • Views: …
More Releases from Exactitude Consultancy
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250
Key Market Highlights
• Increasing focus on road maintenance and resurfacing projects
• Growing demand for efficient and precision milling…
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248
Key Market Highlights
• Growing adoption of automated credit risk assessment tools
• Increasing focus on working capital and cash flow management
• Integration…
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246
Key Market Highlights
• Growing adoption of VoIP and…
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244
Key Market Highlights
• Rapid growth of…
More Releases for Joint
"Joint Genesis Launches Revolutionary Natural Supplement for Joint Pain Relief & …
Joint Genesis has officially launched its breakthrough natural supplement designed to provide effective joint pain relief, improve mobility, and support long-term joint regeneration. This scientifically inspired formula combines powerful natural ingredients to help adults maintain an active lifestyle, reduce stiffness, and support overall joint health. Joint GenesisTM is ideal for anyone looking for a safe, natural alternative to traditional painkillers. Customers can purchase the supplement online at https://us-jointgenesisis.com
and experience…
Arthro MD+ Joint Support - Enhance Mobility And Joint Stability!
As we age or engage in physically demanding activities, our joints often take the brunt of the damage. Stiffness, pain, and reduced flexibility can limit mobility and affect our quality of life. This is where Arthro MD+ Joint Support comes into play. In this comprehensive guide, we will explore everything you need to know about this joint supplement, from its benefits to how it works, customer reviews, and more. By…
Pharma Flex RX Joint Support™ Healthy Joint Mobility Flexibility!
Are you tired of living with joint pain, inflammation, and arthritis? Pharma Flex RX Joint Support is here to help. This is made to ease your joint pain and support your health. It uses natural ingredients that work together to fix the real causes of your joint pain. This means you can move freely and enjoy your life again.
● Product Name - Pharma Flex RX Joint Support
● Results - In…
BioDynamix Joint Genesis - Time To Say Bye To Joint Pain (Joint Genesis Reviews)
What is BioDynamix Joint Genesis?
BioDynamix Joint Genesis is a doctor-formulated supplement designed to treat joint pain and discomfort. The formula rejuvenates and restores your joints, offering a pain-free life.
BioDynamix Joint Genesis ensures you enjoy flexibility, movement, and independence for a long time. It soothes all kinds of joint inflammation and combats stiffness. The formula works by addressing the underlying cause of joint issues.
BioDynamix Joint Genesis works for adults between ages…
Revolutionizing Sacroiliac Joint Treatment: Minimally Invasive Sacroiliac Joint …
Minimally Invasive Sacroiliac Joint Fusion (MIS-SIJ Fusion) is a surgical procedure for treating sacroiliac joint disorders, where the sacroiliac joint is stabilized through minimally invasive techniques. MIS sacroiliac joint fusion is a less invasive alternative to traditional open sacroiliac joint fusion and is gaining popularity among patients and healthcare providers. The MIS sacroiliac joint fusion market is expected to grow significantly in the coming years, driven by the increasing demand…
Flexotone Joint Pain Relief Reviews: Get Relief from Joint Pain & Arthritis
Joint pain & inflammation has come to be an instead usual problem among older consumers, as well as they are frequently entrusted to identify exactly how to deal with these problems with a topical cream or resting. Nevertheless, the makers behind Flexotone think that the reason behind this concern has every little thing to do with something that takes place within the joints. This trouble triggers unbelievable pain; however Big…
